(For a live blog on European stocks, type LIVE/ in an Eikon news window)
* STOXX 600 up for third straight session
* China, UK researchers make progress in coronavirus treatment
* Novo Nordisk , Valmet, Infineon rally after results
* GlaxoSmithKline, Imperial Brands at bottom of STOXX 600
* Airbus slips on halting output at China plant
(Updates to close)
By Susan Mathew
Feb 5 (Reuters) - A clutch of upbeat earnings and reports of progress in treatment for the fast-spreading coronavirus helped to push European shares towards record highs on Wednesday.
Drugmaker Novo Nordisk NOVOb.CO rose 4.6% and industrial company Valmet VALMT.HE and chipmaker Infineon IFXGn.DE both surged more than 10% after results, taking the pan-European stock benchmark STOXX 600 index up 1.2% in its third day of gains.
The index is now just 0.3% shy of record highs hit last month. The rally this week comes after a virus outbreak in China sent markets into a tailspin as investors gauged the potential economic damage from production and supply disruptions. Wednesday, reports from China and the UK that researchers are closing in on a vaccine to treat the virus, lifted sentiment as the death toll in China moved closer to 500. sectors such as autos .SXAP , technology .SX8P and basic materials .SXPP were among the strongest performers.
"It is driven by what we see around the coronavirus and more importantly, the reporting season so far has been pretty reasonable across a number of different sectors," said Will James, deputy head of European equities at Aberdeen Standard Investments.
Companies listed on the STOXX 600 are forecast to report 1.2% earnings growth in the fourth quarter, just a touch below the 1.3% growth rate expected last week, according to the latest data from I/B/E/S Refinitiv. This would follow three straight quarters of declining profits. showing an acceleration of euro zone business activity in January, added to the upbeat mood. tempering the positive expectations was a near 7% drop in cigarette maker Imperial Brands Plc IMB.L after it forecast a fall in its first-half profit, while GlaxoSmithKline GSK.L slipped after missing fourth-quarter earnings forecasts. Airbus AIR.PA fell after the company said it was prolonging a planned closure of its final assembly plant in Tianjin, China, as a result of the coronavirus emergency.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.